Prophage inductive efficiency of alkylating agents and radiations

Analysis of DNA-phosphate adducts in vitro using miniaturized LC-ESI-MS/MS and column switching: phosphotriesters and alkyl cobalamins

DNA-phosphate adducts are known to be formed by a variety of alkylating agents. Due to little or no repair of DNA-phosphate adducts, these adducts may offer increased possibilities of both identifying and quantifying DNA adducts. The formation of DNA-phosphate adducts leads to a complete esterification of the phosphate group giving rise to a phosphotriester configuration. This work consists of the characterization of ethyl phosphotriesters (Ethyl PTE) using miniaturized LC-ESI-MS/MS and column switching in enzymatic hydrolysate of DNA treated in vitro with the model compound N-ethyl-N-nitrosourea (ENU). In vitro ENU-treated DNA was enzymatically degraded using nuclease P1, phosphodiesterase, and alkaline phosphatase. The use of column switch allowed for large-volume injections, where unmodified nucleosides were discarded in the loading step. The analytes were forward flushed to the analytical column in the eluting step and separated using a linear gradient. Ten different ethyl PTEs (dGpEtdG, dApEtdA, dCpEtdC, TpEtT, dGpEtdA, dGpEtdC, dGpEtT, dApEtdC, dApEtT, and dCpEtT) were characterized by their masses and CAD product ion spectra. Measurements of accurate masses were carried out yielding experimental masses within 5 ppm of the calculated masses for 9 of the 10 ethyl PTEs. For comparison, the enzymatic hydrolysate of ENU-treated DNA was subjected to transalkylation of the DNA-phosphate adducts by cob(I)alamin. Formed ethyl-cobalamins were analyzed according to earlier developed methods. The limit of detection of an alkyl-cobalamin standard and an alkyl PTE standard was 2 fmol and 5 fmol, respectively.

International Commission for Protection Against Environmental Mutagens and Carcinogens. Working paper no. 6. Estimation of genetic risks of exposure to chemical mutagens: relevance of data on spontaneous mutations and of experience with ionizing radiation

This paper examines the impact of advances in knowledge on the molecular biology of human Mendelian diseases on the estimation of genetic risks of exposure to ionizing radiation and to chemical mutagens. More specifically, it addresses the question of whether and to what extent naturally occurring Mendelian diseases can be used as a baseline for efforts in this area. Data on the molecular nature and mechanisms of origin of spontaneous mutations underlying naturally occurring Mendelian diseases and on radiation-induced mutations in experimental systems suggest that for ionizing radiation, naturally occurring Mendelian diseases may not constitute an entirely adequate frame of reference and that current risk estimates for this class of diseases are conservative; these estimates however provide a margin of safety in formulating radiation protection guidelines. Currently available data on mechanisms and specificities of action of chemical mutagens, molecular dosimetry, repair of chemically induced adducts in the DNA, adduct-mutation relationships etc., permit the tentative conclusion that naturally occurring Mendelian diseases may provide a better baseline for genetic risk estimation for chemical mutagens than for ionizing radiation. With both ionizing radiation and chemical mutagens, the question of which Mendelian diseases are potentially inducible will become answerable in the near future when more molecular data on human genetic diseases become available. It is therefore essential that risk estimators keep abreast of advances in human genetics and integrate these into their conceptual framework. However, induced Mendelian diseases (especially the dominant ones which are of more immediate concern) are likely to represent a very small fraction of the adverse genetic effects of induced mutations. More attention therefore needs to be devoted to studies on the heterozygous effects of induced mutations.

DNA adduct formation by 12 chemicals with populations potentially suitable for molecular epidemiological studies

DNA adduct formation, route of absorption, metabolism and chemistry of 12 hazardous chemicals are reviewed. Methods for adduct detection are also reviewed and approaches to sensitivity and specificity are identified. The selection of these 12 chemicals from the Environmental Protection Agency list of genotoxic chemicals was based on the availability of information and on the availability of populations potentially suitable for molecular epidemiological study. The 12 chemicals include ethylene oxide, styrene, vinyl chloride, epichlorohydrin, propylene oxide, 4,4'-methylenebis-2-chloroaniline, benzidine, benzidine dyes (Direct Blue 6, Direct Black 38 and Direct Brown 95), acrylonitrile and benzyl chloride. While some of these chemicals (styrene and benzyl chloride, possibly Direct Blue 6) give rise to unique DNA adducts, others do not. Potentially confounding factors include mixed exposures in the work place, as well the formation of common DNA adducts. Additional research needs are identified.

International Commission for Protection Against Environmental Mutagens and Carcinogens. Dosimetry of genotoxic agents and dose-response relationships of their effects

Dose-response relationships and determination of dose of mutagens and carcinogens are summarized and discussed on the basis of conceptual and kinetic aspects. Different dose definitions may be referred to steps in the chain of events from exposure (or emission) to observed effects. A system is applied to show the influence of various processes on the kinetics of the transfers between consecutive steps. The same system illustrates processes influenced by protraction and fractionation of dose, synergists, comutagens/cocarcinogens, heritable factors, etc. The response at a given dose is expected to depend on the product of consecutive transfer functions. An application of general rules of chemical kinetics shows that when a chemical is introduced at a sufficiently low level, all processes affecting the transfers and therefore the transfer functions themselves become first-order, provided the induction status of enzymes and the cell-division rate remain constant. Under the same conditions, dose-response relationships are expected to be linear, i.e. without "safe" thresholds. However, present knowledge of the kinetics of repair at low levels of DNA damage and of the kinetics of induction of repair functions is not enough complete to be decisive. These considerations and the fact that observed dose-response data in some cases indicate the existence of thresholds but in others appear able to reject the threshold hypothesis lead to the conclusion that, generally, dose-response curves are most probably linear down to dose zero. However, certain mutagens/carcinogens give rise to lesions repaired so effectively that quasi-thresholds appear in certain subpopulations or organs.

Lack of additive effect in mutagenesis of E. coli by UV-light and ethylene oxide

The interaction of UV-irradiation and ethylene oxide (EtO) on forward mutation frequencies in the lacI gene of E. coli strains 3835 and 3951 and on the frequency of leu+ revertants in E. coli WU36-10-89 were studied. Pre-exposure to low doses of UV-light with the following treatment by low and intermediate doses of EtO showed lack of additive effect in the mutagenic response in all strains studied. The number of mutants actually obtained in the respective experiments was much lower than the additive model predicted.

Estimation of genetic risks of alkylating agents. VI. Exposure of mice and bacteria to methyl bromide

Methyl bromide was studied in a forward mutation system of E. coli to evaluate the relationship between dose and mutagenic response. The compound had a high toxicity and a low mutagenic efficiency, as expected from the high s value. The mutagenic effectiveness was estimated to be 1 mutation per 10(8) surviving bacteria per mM . h, in reasonable agreement with expectation from reaction kinetic data. To study the possibilities of using hemoglobin alkylation for an estimation of DNA alkylation in vivo, mice were treated with 14C-labeled methyl bromide. The degree of alkylation of DNA, determined in liver and spleen, was considerably lower than expected (200 and 20 times, respectively) from the degree of alkylation of hemoglobin and from the relative reactivities of DNA and hemoglobin towards methyl bromide in vitro. when hemoglobin alkylation is used for quantitative risk estimations, a correction factor has to be applied by taking into account the difference between the dose in red blood cells and the dose in the compartments of DNA.

Alkylation of macromolecules for detecting mutagenic agents

At present, experiments with laboratory organisms and epidemiological studies are the major source of information about the genetic toxicology of environmental agents. Laboratory systems are limited in value by difficulties in the interpretation of negative results, in quantitation, and in extrapolation from experimental effects of chemicals to specific levels of activity in man. Epidemiologic methods measure effects in man but are weakened by long latency times, confounding environmental factors, imprecise endpoints, and high background levels, which reduce sensitivity. Several methodological improvements in genetic toxicity testing are needed, including increased resolving power, greater relevance of observations to effects in man, techniques for evaluating interactions of compounds in chemically complex systems, and improvements in quantitative risk assessment. Because most genetically toxic agents ultimately react as electrophilic agents with nucleophilic centers in cellular macromolecules, the quantitative analysis of the resulting products may be a useful approach to the evaluation of the risks posed by exposure to specific chemicals. The main nucleophilic centers in biological macromolecules are thiol and thioether sulfurs, nitrogens in amino groups and rings, and oxygen atoms. Using the laws of reaction kinetics of alkylation and the observed kinetics of induced mutagenic effects, it is possible to relate the formation of alkylated products in macromolecules to genetic toxicity. The alkylation of amino acids (eg, histidine and cysteine) in hemoglobin can be measured with sufficient sensitivity and accuracy to use it as a monitor of exposure to alkylating agents. By determining the degree of alkylation of a specific center, it is possible to calculate the internal dose of an agent and, because erythrocyte life-spans are relatively uniform, the incremental daily exposure of an individual to an alkylating agent. Dosimetry can be equated with radiologic dose so that exposure can be expressed in rad-equivalents and the effects of specific agents compared quantitatively to biologically well-characterized doses of radiation.

Molecular dosimetry of the chemical mutagen ethyl methanesulfonate: quantitative comparison of mutation induction in Escherichia coli, V79 Chinese hamster cells and L5178Y mouse lymphoma cells, and some cytological results in vitro and in vivo

Molecular dosimetry studies were carried out to measure the extent of binding of radio-labeled ethyl groups to the DNA of Escherichia coli, V79 Chinese hamster cells and L5178Y mouse lymphoma cells treated with ethyl methanesulfonate (EMS). The results show that (1) the amount of ethylation of the DNA is similar in these cells when treatment conditions are identical, (2) the relationship between dose to DNA (ethylations per nucleotide) versus exposure (mM applied concentration) is non-linear in the sense that less alkylation of the DNA is observed at the higher exposures than would be predicted on the basis of proportionality between dose to DNA and exposure, and (3) the non-linearity of the genetic response in the bacterial cells is not reflected in a non-linearity of the alkylation of the DNA in those cells. Quantitative comparison of the frequencies of gene mutations in the various systems shows that the mutation frequency per unit of DNA alkylation is heterogeneous among the mammalian cell systems and that the frequencies observed in the bacterial cells fall within the range observed with mammalian cells. Alkylation of the DNA in the bone marrow, testis and liver of Swiss random-bred mice was also measured. The results support the conclusion that the distribution of the compound to the various tissues is rapid and probably uniform. Quantitative assessment of the cytological data (micronuclei, sister-chromatid exchanges, etc.) on the basis of dose was not as useful because of the low efficiency of EMS for inducing cytologically observable damage.

Determination of reaction rate constants for alkylation of 4-(p-nitrobenzyl) pyridine by different alkylating agents

The rate constants have been determined for the reaction between some different alkylating agents and 4-(p-nitrobenzyl) pyridine (NBP) in methanol. These constants have been compared with those for alkylation of aniline in water. All the constants were lower in methanol than in water but in different degrees. The rate constants of the different alkylating agents have been calculated at a nucleophilic strength n=2. The genetic risk defined as the degree of alkylation of a nucleophile (n=2) is equivalent to the rate constant kn=2 and the target dose. The dependence of the genetic risk on the rate constant (kn=2) is discussed.

Genetic effects of dimethyl sulfate, diethyl sulfate, and related compounds

DMS and DES are monofunctional alkylating agents that have been shown to induce mutations, chromosomal aberrations, and other genetic alterations in a diversity of organisms. They have also been shown to be carcinogenic in animals. As an alkylating agent, DMS is a typical SN2 agent, attacking predominantly nitrogen sites in nucleic acids. DES is capable of SN1 alkylations as well as SN2 and thereby causes some alkylation on oxygen sites including the O6-position of guanine which is thought to be significant in mutagenesis by direct mispairing. The mutagenicity of DMS is better explained in terms of indirect, repair-dependent processes. With respect to both alkylating activity and genetic effects, striking similarities are found between DMS and MMS and between DES and EMS. In most systems where they have been tested, both DMS and DES are mutagenic. Results of many of the mutagenesis studies involving these compounds and other alkylating sulfuric acid esters are summarized in Tables 6, 7, 8, 9 and 10 of this review. Most data are consistent with these agents acting primarily as base-pair substitution mutagens. In the case of DES, strong specificity for G.C to A.T transitions has been reported in some systems but has not been clearly supported in some others. Low levels of frameshift mutations of the deletion type are also likely. In addition to the induction of mutations, recombinogenic and clastogenic effects have been described.